Skip to main content

Table 1 Clinicopathological and molecular genetic characteristics of the COAD patients.

From: The CIMP-high phenotype is associated with energy metabolism alterations in colon adenocarcinoma

 Patient

Age

Gender

Grade

TNM

stage

KRAS status

NRAS status

BRAF status

MSI status

Relative mRNA level

ENO2

OGDHL

PKLR

CIMP-high COAD patients

 Pat1

63

F

2

T3N1M0

WT

WT

c. 1799 T → A (p.Val600Glu)

MSI-H

25↓

1.9↑

1.1↑

 Pat2

76

M

2

T3N0M0

WT

WT

c. 1799 T → A (p.Val600Glu)

MSI-H

25↓

2.6↑

2.1↑

 Pat3

69

F

2

T3N0M0

WT

WT

c. 1799 T → A (p.Val600Glu)

MSI-H

25↓

4.0↑

2.4↑

 Pat4

62

F

2

T3N1M0

WT

WT

c. 1799 T → A (p.Val600Glu)

MSI-H

20↓

2.0↑

1.4↑

 Pat5

77

F

3

T2N0M0

WT

WT

c. 1799 T → A (p.Val600Glu)

MSI-H

1.1↓

1.1↑

1.3↓

 Pat6

55

F

2

T3N0M0

WT

WT

c. 1799 T → A (p.Val600Glu)

MSS

4.3↑

2.8↓

1.2↑

 Pat7

76

F

2

T3N1M0

WT

WT

WT

MSS

2.5↓

1.7↑

2.4↑

Non-CIMP COAD patients

 Pat8

85

M

2

T3N0M0

WT

WT

WT

MSS

1.1↓

3.5↑

1.1↓

 Pat9

83

M

2

T3N0M0

WT

WT

WT

MSS

7.4↑

1.7↑

5.1↑

 Pat10

67

F

2

T3N0M0

WT

WT

WT

MSS

3.2↑

1.0

5.7↑

 Pat11

77

F

2

T3N0M0

WT

WT

WT

MSS

24.8↑

14.3↓

10.2↑

 Pat12

59

F

3

T3N1M0

WT

WT

WT

MSS

5.7↑

4.8↓

1.7↓

 Pat13

69

F

2

T4N1M0

WT

WT

WT

MSS

3.8↑

4.8↓

7.7↑

 Pat14

55

F

2

T3N0M0

WT

WT

WT

MSS

30.0↑

2.9↓

13.3↑

  1. Note: ↑ - expression increase; ↓ - expression decrease.